| |
| |
|
| Insider
Information: |
Ali-Jackson Kamil |
| Relationship: |
|
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
215,728 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$251,556 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
215,728 |
|
|
| Total
Value |
$251,556 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aclaris Therapeutics, Inc. |
ACRS |
Chief Legal Officer |
2022-01-03 |
160,214 |
|
0 |
Premium* |
|
|
PDS Biotechnology Corp |
PDSB |
|
2021-06-15 |
11,764 |
2021-06-15 |
0 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2023-05-26 |
43,750 |
2022-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
43,750 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
18,750 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2022-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,518 |
160,214 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
|
• • – |
2021-06-15 |
4 |
B |
$8.50 |
$99,994 |
D/D |
11,764 |
11,764 |
0.01 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-06-03 |
4 |
AS |
$21.96 |
$208,421 |
D/D |
(9,492) |
122,196 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-06-02 |
4 |
AS |
$21.50 |
$651,664 |
D/D |
(30,119) |
131,688 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,189 |
176,807 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-06-01 |
4 |
AS |
$22.72 |
$345,299 |
D/D |
(15,000) |
161,807 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-07 |
4 |
AS |
$23.23 |
$127,392 |
D/D |
(5,416) |
143,618 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-07 |
4 |
OE |
$10.66 |
$57,735 |
D/D |
5,416 |
149,034 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-06 |
4 |
AS |
$23.32 |
$351,453 |
D/D |
(15,000) |
143,618 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-06 |
4 |
OE |
$10.66 |
$159,900 |
D/D |
15,000 |
158,618 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-05 |
4 |
AS |
$23.97 |
$359,713 |
D/D |
(15,000) |
143,618 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-05 |
4 |
OE |
$10.66 |
$159,900 |
D/D |
15,000 |
158,618 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-04 |
4 |
OE |
$10.66 |
$159,900 |
D/D |
15,000 |
158,618 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-04 |
4 |
AS |
$23.61 |
$355,187 |
D/D |
(15,000) |
143,618 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-03 |
4 |
AS |
$24.46 |
$368,818 |
D/D |
(15,000) |
143,618 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-05-03 |
4 |
OE |
$10.66 |
$159,900 |
D/D |
15,000 |
158,618 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-03-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,500 |
114,696 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-03-02 |
4 |
D |
$23.25 |
$44,315 |
D/D |
(1,906) |
143,618 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,637 |
145,524 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-03-01 |
4 |
D |
$24.06 |
$118,712 |
D/D |
(4,934) |
138,887 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,175 |
143,821 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,875 |
127,964 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Chief Legal Officer |
• – – |
2021-02-01 |
4 |
D |
$21.35 |
$28,139 |
D/D |
(1,318) |
126,646 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
